Precigen Inc. (PGEN)

[shub]

Kirk Has a great eye for acquisitions and a long term perspective on their pay off.
The advantage GNVC will enjoy in XON is access to XON's brilliant researchers and synthetic biology expertise. As well as the larger companies financial backing.
XON is a bit like a bio-mutual fund as you noted, with a real diversity of bets.
So many of my small bios are almost one trick ponies that rise or fall on the fate of their lead product.